CAMELOT

(redirected from Camelots)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Comparison of Amlodipine vs Enalapril to Limit Occurrences of Thrombosis. A trial which enrolled 1991 patients, investigating the effect of antihypertensive drugs on cardiovascular events in patients with coronary artery disease and normal blood pressure
Conclusion Administration of amlodipine to patients with coronary artery disease and normal blood pressure resulted in reduced adverse cardiovascular events and slowed progression of atherosclerosis

CAMELOT

Cardiology A clinical trial–Comparison of Amlodipine versus Enalapril/Lipitor® to Limit Occurrences of Thrombosis. See Enalapril.
Mentioned in ?
References in periodicals archive ?
David Excell, co-founder of Featurespace, added: We really admire Camelots commitment to remaining at the forefront of player protection.
Imperial Innovations' portfolio company Featurespace, the provider of adaptive behavioural analytics, and the National Lottery operator, Camelot, have announced the start of a project to enhance Camelot's existing processes for identifying and protecting online players at potential risk of harmful play.
Featurespace and Camelot have been carrying out in-depth research and analysis over the past two years to understand patterns of online player behaviour in historic datasets.
Camelot is the first lottery operator to engage Featurespaces award winning predictive, machine learning analytics to support players online.